Norwalk virus

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Takeda

Conditions

Acute GastroenteritisGastroenteritis NorovirusNorwalk Virus Infection

Phase 1

New Challenge Pool of Norwalk Virus Inoculum

CompletedNCT00138476

National Institute of Allergy and Infectious Diseases (NIAID)Gastroenteritis Norovirus

Start: 2004-08-31End: 2012-09-30Updated: 2014-05-09

Norwalk Vaccine Study

CompletedNCT00973284

TakedaAcute Gastroenteritis, Norwalk Virus Infection

Start: 2009-08-04End: 2010-08-18Updated: 2017-08-08

Related Papers

Determination of the 50% Human Infectious Dose for Norwalk Virus

The Journal of Infectious Diseases2013-11-18314 citations

Norovirus vaccine against experimental human Norwalk Virus illness.

2011-12-01346 citations

Serological correlate of protection against norovirus-induced gastroenteritis.

2010-10-01232 citations